Dimensional Fund Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.31M | Buy |
2,082,055
+1,751,219
| +529% | +$7.18M | ﹤0.01% | 2376 |
|
|
2025
Q4 | $1.11M | Buy |
330,836
+240,463
| +266% | +$624K | ﹤0.01% | 2845 |
|
|
2025
Q3 | $118K | Hold |
90,373
| – | – | ﹤0.01% | 3171 |
|
|
2025
Q2 | $64.8K | Sell |
90,373
-28
| -0% | -$22 | ﹤0.01% | 3217 |
|
|
2025
Q1 | $133K | Sell |
90,401
-128,021
| -59% | -$305K | ﹤0.01% | 3169 |
|
|
2024
Q4 | $968K | Buy |
218,422
+10,149
| +5% | +$41.2K | ﹤0.01% | 2921 |
|
|
2024
Q3 | $858K | Sell |
208,273
-5,346
| -3% | -$28.7K | ﹤0.01% | 2934 |
|
|
2024
Q2 | $1.39M | Buy |
213,619
+69,848
| +49% | +$494K | ﹤0.01% | 2851 |
|
|
2024
Q1 | $1.25M | Sell |
143,771
-2,938,040
| -95% | -$35.7M | ﹤0.01% | 2884 |
|
|
2023
Q4 | $35.3M | Sell |
3,081,811
-2,435,165
| -44% | -$24.1M | 0.01% | 1673 |
|
|
2023
Q3 | $53.1M | Sell |
5,516,976
-94,092
| -2% | -$922K | 0.02% | 1302 |
|
|
2023
Q2 | $59.7M | Buy |
5,611,068
+1,001,989
| +22% | +$10.8M | 0.02% | 1229 |
|
|
2023
Q1 | $48.5M | Buy |
4,609,079
+946,481
| +26% | +$10.6M | 0.02% | 1345 |
|
|
2022
Q4 | $45.4K | Buy |
3,662,598
+330,975
| +10% | +$3.75M | 0.01% | 1380 |
|
|
2022
Q3 | $34.5M | Buy |
3,331,623
+252,333
| +8% | +$2.86M | 0.01% | 1493 |
|
|
2022
Q2 | $35.5M | Buy |
3,079,290
+4,760
| +0.2% | +$56.1K | 0.01% | 1546 |
|
|
2022
Q1 | $38.7M | Sell |
3,074,530
-2,459
| -0.1% | -$28.2K | 0.01% | 1594 |
|
|
2021
Q4 | $35.9M | Buy |
3,076,989
+119,916
| +4% | +$1.47M | 0.01% | 1644 |
|
|
2021
Q3 | $38.6M | Buy |
2,957,073
+277,543
| +10% | +$3.59M | 0.01% | 1599 |
|
|
2021
Q2 | $34.5M | Buy |
2,679,530
+734,831
| +38% | +$8.41M | 0.01% | 1726 |
|
|
2021
Q1 | $21.7M | Buy |
1,944,699
+637,300
| +49% | +$6.73M | 0.01% | 1994 |
|
|
2020
Q4 | $14.9M | Buy |
1,307,399
+292,661
| +29% | +$3.2M | 0.01% | 2110 |
|
|
2020
Q3 | $9.13M | Buy |
1,014,738
+140,922
| +16% | +$1.4M | ﹤0.01% | 2236 |
|
|
2020
Q2 | $9.02M | Buy |
873,816
+359,612
| +70% | +$3.68M | ﹤0.01% | 2243 |
|
|
2020
Q1 | $5.19M | Buy |
514,204
+382,409
| +290% | +$4.49M | ﹤0.01% | 2392 |
|
|
2019
Q4 | $1.75M | Buy |
+131,795
| New | +$1.45M | ﹤0.01% | 2890 |
|
|
2019
Q1 | – | Sell |
-29,099
| Closed | -$252K | – | 3454 |
|
|
2018
Q4 | $252K | Buy |
+29,099
| New | +$334K | ﹤0.01% | 3254 |
|
|
2015
Q1 | – | Sell |
-757
| Closed | -$10K | – | 3364 |
|
|
2014
Q4 | $10K | Hold |
757
| – | – | ﹤0.01% | 3457 |
|
|
2014
Q3 | $8K | Hold |
757
| – | – | ﹤0.01% | 3491 |
|
|
2014
Q2 | $10K | Hold |
757
| – | – | ﹤0.01% | 3535 |
|
|
2014
Q1 | $8K | Buy |
+757
| New | +$8.51K | ﹤0.01% | 3555 |
|
Other funds holding IRWD
AC
SCM
VPM
VCM
Dimensional Fund Advisors's IRWD Position: Q1 2026 in Review
Dimensional Fund Advisors increased its Ironwood Pharmaceuticals (IRWD) stake by 529% in Q1 2026, buying an estimated $7.18M and bringing the position to 2,082,055 shares worth $7.31M. The position accounts for ﹤0.01% of the portfolio, ranked #2376.
Dimensional Fund Advisors first reported a position in IRWD in Q1 2014 and has held it in 31 quarters since. The position peaked at $59.7M in Q2 2023. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- Dimensional Fund Advisors held 2,082,055 shares of Ironwood Pharmaceuticals worth $7.31M as of Q1 2026.
- Dimensional Fund Advisors bought 1,751,219 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $7.18M.
- Ironwood Pharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2376 holding.
- Dimensional Fund Advisors first reported a position in Ironwood Pharmaceuticals in Q1 2014 and has held it in 31 quarters since.
- Dimensional Fund Advisors's Ironwood Pharmaceuticals position peaked at $59.7M in Q2 2023.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.